{
    "complex": true,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": false,
    "type": "ETP",
    "complex_factors": [
        "5x daily leverage",
        "synthetic replication via futures swaps",
        "rolling futures strategy",
        "counterparty risk",
        "non-UCITS structure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree NASDAQ 100 5x Daily Leveraged ETP is classified as complex under MiFID II due to several key factors: 1) It uses 5x daily leverage, which significantly amplifies both potential gains and losses, making it unsuitable for retail investors without specialized knowledge. 2) The product achieves its exposure through synthetic replication via futures contracts and swaps, introducing counterparty risk and roll costs. 3) The rolling futures strategy introduces additional complexity from contango/backwardation effects. 4) The product is not UCITS-compliant, and the KIID explicitly states it is 'not simple and may be difficult to understand.' 5) The risk profile is classified as 7/7, the highest level, and the product warns it is intended only for informed investors who understand leveraged products and can bear capital loss. The combination of leverage, synthetic replication, and the need for daily monitoring makes this product clearly complex under MiFID II standards.",
    "confidence": 95
}